Bauman, J. E., Ohr, J., Gooding, W. E., Ferris, R. L., Duvvuri, U., Kim, S., . . . Stabile, L. P. (2020). Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer. Cancers (Basel).
Chicago Style CitationBauman, Julie E., et al. "Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer." Cancers (Basel) 2020.
MLA CitationBauman, Julie E., et al. "Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer." Cancers (Basel) 2020.
Warning: These citations may not always be 100% accurate.